Synthace Ltd.

https://www.synthace.com

Twitter: @synthace

Synthace is developing Antha, a language and software platform specifically for biology that lets researchers aim higher and achieve better results, faster. Antha is designed to make reproducible and scalable workflows that can be readily edited and shared, and easily automated on labs’ existing equipment. In 2016, the World Economic Forum included Synthace in its selection of the world’s 30 most promising Technology Pioneers that are helping shape the Fourth Industrial Revolution – a technological revolution that will fundamentally alter the way we live, work and relate to one another. *

	Start	2011-01-01 splitoff
	Predecessor	University College London (UCL)
	Industry	synthetic biotechnology
	Industry 2	Antha language and software platform for biology
	Person	Fell, Tim (Synthace 201812 CEO)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	195 Wood Lane The Westworks
	City	W12 7FQ London
	Tel	+44-20-3976-7676
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Oxford Biomedica plc. (8/11/17). "Press Release: Oxford BioMedica Announces a £2 Million Two-year Collaboration Co-funded by Innovate UK". London.

		Record changed: 2019-08-18

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Synthace Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]